This compound is an Fmoc-protected, N-methylated derivative of L-leucine, used as a building block in solid-phase peptide synthesis. Its structure incorporates a fluorenylmethoxycarbonyl (Fmoc) group for temporary protection of the amino function, enabling the sequential assembly of peptides.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 103478-62-2
Fmoc-N-Methyl-L-alanine
pharmaceutical intermediate
Fmoc-N-methyl-L-isoleucine
pharmaceutical intermediate
FMoc-alpha-Me-D-Phe(2-F)-OH
pharmaceutical intermediate
Fmoc-N-(2,4-dimethoxybenzyl)-Gly-OH
pharmaceutical intermediate
Fmoc-L-propargylglycine
pharmaceutical intermediate
2-Amino-4-(4-methylpiperazin-1-yl) benzoic acid tertbutyl ester
pharmaceutical intermediate
4-(4-Methylpiperazin-1-yl)-2-(2,2,2-trifluoro-N-(tetrahydro-2H-pyran-4-yl)acetamido)benzoic acid 2,2,2-trifluoroacetate
pharmaceutical intermediate
N-[1-(Hydroxymethyl)cyclopropyl]carbamic acid phenylmethyl ester
pharmaceutical intermediate
(2S)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]-4-methylpentanoic acid
BUJQSIPFDWLNDC-FQEVSTJZSA-N
CC(C)C[C@@H](C(=O)O)N(C)C(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13